Mette Kirstine Agger
CIK 1722234 · last filed 2025-10-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$40.75M
Companies
4
Total Filings
15
Lifetime Open-Market Net
$15.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| scPharmaceuticals Inc. (SCPH) Delisted | Director | 3,183,986 | $5.67 | $18.05M | $9.17M | 9 | 2025-10-07 |
| LXEO | Director | — | $4.37 | — | $0 | 3 | 2025-06-30 |
| IMRA | Director | 1,432,722 | $17.02 | $24.38M | $3.00M | 1 | 2020-03-16 |
| TRVI | Director | 1,151,544 | $14.21 | $16.36M | $3.75M | 2 | 2019-05-13 |
Recent Filings · Page 2 of 2
15 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-13 | TRVI | Mixed | +1,151,544 | $3.75M | EDGAR |
| 2019-05-08 | TRVI | Grant (A) | — | $0 | EDGAR |
| 2018-06-21 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-13 | scPharmaceuticals Inc. (SCPH) Delisted | Buy (P) | +654,762 | $9.17M | EDGAR |
| 2017-11-21 | scPharmaceuticals Inc. (SCPH) Delisted | Conv (C) | +2,529,224 | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.